Dynaris

We set new standard in oxygen therapy; 7 patents, FDA, superior therapy, & more

https://wefunder.com/dynaris

Total raised on Wefunder: 179980

Total investors: 43

Quick facts

  • FDA 510 (K), EUA, ISO-13485 Quality System, FDA registered manufacturing in-house, Ready to go!
  • 5.9 million patients on oxygen in the U.S. alone growing to over 7 million patients in 2023.
  • Protected by 7 U.S. Patents, more pending, foreign patents pending.
  • Experienced team with a history of success, from concept through acquisition. CEO has 28 patents
  • Superior oxygen therapy for patients. Sets a new therapeutic standard for oxygen patients.
  • Oxygen therapies are expanding to other areas; i.e. cluster headaches and wound healing treatments
  • Additional products in development expand our technologies into other therapeutic market segments.

Team profiles

Featured investor profiles

Dynaris

We set new standard in oxygen therapy; 7 patents, FDA, superior therapy, & more

Funded badge
Last Funded November 2021

$179,980

raised from 43 investors
Pitch Video
Investor Panel

Investor Panel

Shu interviewed Dynaris on September 30, 2021. Play Video
Shu Li
Shu Li
CEO and co-founder of Petri-Bio
Strengths
says, "The company has developed the device and technology with a very solid patent family. The CEO Dr.Aylsworth has been in this industry for several decades with extensive experience."
Advice
says, "I think the pitch video is a bit longer than average and easy to lose the audience. Making it shorter and focus on the competitive advantage and market potential would further improve the campaign"

What Investors Say

Angel Investor
LEAD INVESTOR
Invested $24,000 this round + $600,000 previously
Oxygen therapy has been a huge part of medical treatment, but little has been done to improve it over the last few decades. The founder, Lon Aylsworth has made it his mission to modernize the understanding and delivery of oxygen. The design improvements are revolutionary and brilliant, but you also wonder why no one ever took this approach before. We are all looking forward to the breakthroughs that will come as a result of this new approach to oxygen therapy.
What People Say